Primary Cutaneous Vasculitis — VA Disability Rating (DC 7826)
Diagnostic Code 7826 · 38 CFR §4.118
What Is It?
Primary cutaneous vasculitis is inflammation of the small blood vessels of the skin, producing palpable purpura — raised purple spots that do not blanch under pressure — most often on the lower legs, sometimes progressing to ulcers and necrotic lesions. The common form is leukocytoclastic vasculitis, and it is triggered by infections, medications, and autoimmune disease. The word primary in the code heading matters: DC 7826 covers vasculitis confined to the skin. Where the same process involves kidneys, lungs, nerves, or the gastrointestinal tract, that is systemic vasculitis and it is rated under the codes for those organ systems, usually to considerably greater effect. Unlike most of the skin schedule, DC 7826 does not use body surface area at all. It rates on episode frequency over the past twelve months and on the level of immunosuppressive therapy required for control, with an explicit alternative of rating as disfigurement (DC 7800) or scars (DC 7801, 7802, 7804, or 7805) where those predominate.
Rating Criteria
| Rating | Criteria |
|---|---|
| 60% | Persistent documented vasculitic episodes refractory to continuous immunosuppressive therapy. This is the maximum schedular evaluation under DC 7826; alternatively, rate as disfigurement of the head, face, or neck (DC 7800) or scars (DC 7801, 7802, 7804, or 7805), depending on the predominant disability. |
| 30% | Recurrent documented vasculitic episodes occurring four or more times over the past 12-month period, and requiring intermittent systemic immunosuppressive therapy for control. |
| 10% | Recurrent documented vasculitic episodes occurring one to three times over the past 12-month period, and requiring intermittent systemic immunosuppressive therapy for control; or, without recurrent documented vasculitic episodes but requiring continuous systemic medication for control. |
Evidence Needed
A skin biopsy showing leukocytoclastic vasculitis is the diagnostic anchor and should be obtained early, ideally within 48 hours of a fresh lesion, since the histology changes quickly. Because the criteria count documented episodes, the record needs a dated entry for each one — clinic visits, urgent care notes, and photographs with dates. The therapy history matters at every tier: which immunosuppressive agents, whether intermittent or continuous, and whether the disease persisted despite continuous therapy, which is the 60 percent criterion. Equally important is the systemic workup, because it can move the claim to an entirely different code: urinalysis and renal function for kidney involvement, ANCA and complement studies, chest imaging, nerve conduction studies for vasculitic neuropathy, and hepatitis serologies.
C&P Exam Tips
Bring a dated episode log — this code counts episodes, and the difference between three and four in a twelve-month period is the difference between 10 percent and 30 percent. Bring photographs of active purpura, since lesions resolve and you will likely be seen between flares. State the immunosuppressive history precisely and, if the disease has continued despite continuous therapy, say that in those words, because refractory disease despite continuous immunosuppression is the 60 percent criterion. Ask whether systemic involvement has been evaluated and mention any numbness, foot drop, joint pain, blood in the urine, abdominal pain, or shortness of breath — those symptoms point to systemic vasculitis and belong under organ-system codes with far higher ceilings.
How to File
File on VA Form 21-526EZ as primary cutaneous vasculitis or leukocytoclastic vasculitis under DC 7826. Attach the biopsy report, a dated episode log, photographs, and the complete immunosuppressive therapy history. If any systemic involvement has been identified — renal, pulmonary, neurological, or gastrointestinal — file those as separate issues under the appropriate body-system codes rather than folding them into the skin claim. Claim residual scarring and ulcer scars under DC 7801 through 7805, and file secondary service connection where a medication for a service-connected condition triggered the vasculitis.
Common Mistakes
The most common mistake is arguing body surface area, which this code does not use. DC 7826 counts episodes and looks at therapy; coverage figures are simply not responsive to the criteria. The second is not documenting episodes contemporaneously, which makes the count unprovable a year later — a photograph with a date and a clinic note for each flare is what carries this claim. The third, and the most consequential, is stopping at the skin. Cutaneous vasculitis is frequently the visible edge of a systemic process, and renal, pulmonary, and neurological involvement are rated under codes that reach far higher than 60 percent. The fourth is failing to state that disease has persisted despite continuous immunosuppression, which is the specific language of the top tier.
Frequently Asked Questions
Why does DC 7826 not use body surface area?
Because vasculitis is an episodic vascular inflammatory process rather than a persistent rash, and the disability it causes tracks how often it flares and how much immunosuppression is needed to hold it down. The criteria are written accordingly: one to three documented episodes with intermittent immunosuppressive therapy for 10 percent, four or more for 30 percent, and persistent disease refractory to continuous immunosuppressive therapy for 60 percent.
What is the difference between cutaneous and systemic vasculitis?
Cutaneous vasculitis is confined to the small vessels of the skin. Systemic vasculitis involves the same inflammatory process in internal organs — kidneys, lungs, nerves, gastrointestinal tract. DC 7826 covers only the primary cutaneous form. Organ involvement is rated under the codes for those systems, which carry far higher ceilings, so a systemic workup is worth pursuing whenever cutaneous vasculitis is diagnosed.
Do I need a biopsy?
It is close to essential, and timing matters. A punch biopsy of a fresh lesion — ideally within about 48 hours of its appearance — showing leukocytoclastic vasculitis establishes the diagnosis; older lesions lose the characteristic findings. The criteria also speak of documented vasculitic episodes, so biopsy-confirmed disease plus a dated episode record is exactly the evidentiary shape this code is asking for.
Can medication cause vasculitis, and does that help my claim?
Yes to both. Drug-induced cutaneous vasculitis is well recognized, with antibiotics, NSAIDs, diuretics, and anticonvulsants among the frequent triggers. If the drug was prescribed to treat a service-connected condition, the vasculitis is a consequence of that disability under 38 CFR §3.310 and is service-connected on a secondary basis. Name the medication, the prescribing facility, the dates, and the primary condition it was treating.